Biocon Ltd. NSE: BIOCON | BSE: 532523

Strong Performer, Getting Expensive

Download real time

378.15 -5.50 (-1.43%)

29.95% Gain from 52W Low

1.4M

NSE+BSE Volume

NSE 10 Dec, 2025 11:34 AM (IST)

Acquisition

Biocon's board approves acquiring Biocon Biologics for a total consideration of Rs 13,841 cr See details

Biocon News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Biocon Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Biocon Ltd.
Rating: 5
Author: Motilal Oswal

Keep track of all breaking news and updates on Biocon from all sources in a single place.

Is Biocon Ltd. worth buying?

734 Votes:

Buy 74.8%

Sell 16.35%

Hold 8.86%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf